Table 3 Surgical Treatments and Outcomes after Inguino-femoral Lymph Node Dissection (ILND)
Fibrin sealant group n = 16 | Control group n = 14 | ||||
|---|---|---|---|---|---|
Variable | No. | % of total | No. | % of total | P value |
Surgical Treatment | |||||
Patients undergoing superficial ILND | 9 | 56 | 11 | 79 | 0.26 |
Patients undergoing superficial + deep ILND | 7 | 44 | 3 | 21 | |
Median length of surgery, minutes (range) | 227 (95–455) | 261 (96–713) | 0.53 | ||
Median estimated blood loss, mL (range) | 50 (0–300) | 75 (0–1075) | 0.75 | ||
Median No. lymph nodes removed (range) | 17.5 (9–56) | 15 (9–38) | 0.07 | ||
Median No. positive lymph nodes (range) | 3 (1–12) | 2 (0–21) | 0.41 | ||
Patients undergoing concurrent limb perfusion | 0 | 0 | 2 | 14 | 0.21 |
Outcomes | |||||
Median time to drain removal, days (range) | 31 (11–45) | 26 (13–74) | 0.59 | ||
Patients with clinically evident seroma | 3 | 19 | 3 | 21 | 1.00 |
Patients with clinically evident seroma requiring drainage | 3 | 19 | 2 | 14 | 1.00 |
Patients with wound infection | 7 | 44 | 7 | 50 | 0.73 |
Major (inpatient management) | 3 | 19 | 2 | 14 | 1.00 |
Minor (outpatient management) | 4 | 25 | 5 | 36 | 0.69 |
Patients with wound dehiscence | 7 | 44 | 5 | 36 | 0.65 |
Major (inpatient management) | 1 | 6 | 0 | 0 | 1.00 |
Minor (outpatient management) | 6 | 38 | 5 | 36 | 0.92 |
Patients with drain issues | |||||
No., number | 1 | 6 | 3 | 21 | 0.32 |